Overview

Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants

Status:
Completed
Trial end date:
2019-07-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the dose-dependent effects of TAK-954 on gastric emptying time of solids in participants with diabetic or idiopathic gastroparesis assessed by scintigraphy.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda